Status:
COMPLETED
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Oular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the treatment of elevated ...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older with open-angle glaucoma (with or without pigment dispersion or pseudoexfoliation) or ocular hypertension.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Patients with any form of glaucoma other than open-angle.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT00691717
Start Date
June 1 2008
End Date
September 1 2009
Last Update
November 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charleston
Charleston, South Carolina, United States, 29414